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Hamartoma is a rare splenic benign tumor usually accidentally detected as a radiologic finding. Preoperative diagnosis poses a
challenge and thus surgery becomes necessary to confirm the clinical suspicion. Laparoscopic splenectomy has gained consensus
as a standard surgical procedure particularly for autoimmune hematological diseases. This former experience has allowed this
technique to be extended to other splenic pathologies. Here we report a case of total laparoscopic splenectomy for a bulky splenic
hamartoma in a young male patient.
1. Introduction
Mass forming splenic tumors are rare. Malignancies include
lymphoma and other less common lesions as primary splenic
sarcoma, plasmacytoma, or metastatic disease from non-
gastrointestinal tumor (e.g., lung melanoma or ovarian
cancer) [1–7]. Benign lesions are exceedingly rare comprising
mostly hemangiomas, cysts and inflammatory pseudotu-
mors [8–12]. Splenic hamartoma is a very rare benign
tumor with an incidence of 3 in 200000 splenectomies at
a single center series [13] and 0,024% to 0,13% in an
autopsies review [14]. Although hamartoma is benign and
usually asymptomatic it is important to distinguish that from
malignancy lesion. Medical imaging improvement has led
an increase in the detection rate of incidentalomas of the
spleen that pose a challenge, due to diagnostic diﬃculties
[12]. As a consequence solitary splenic tumors may require
splenectomy to assure a definitive histological diagnosis.
Laparoscopic surgery has become the standard technique for
both benign and malignant disease [15]. Minimally invasive
surgery is particularly suitable for benign disease, enclosing
hamartoma. Nevertheless to our knowledge only a few
reports focusing on splenic hamartoma laparoscopic surgery
have been published [16–19]. In this paper we describe a
case of splenic hamartoma treated with totally laparoscopic
approach.
2. Case Report
A 28-year-old Italianmale presented at the ER in August 2011
with diarrhea and an antibiotics refractory fever. Laboratory
findings did not show any significant problem, apart from a
mild hypertransaminasemia: (ALT 65 u/L AST 46 u/L).
The patient was discharged with the indication for
further investigations. Abdominal ultrasonography was per-
formed two weeks later, showing normal liver, biliary ducts,
and pancreas morphology. Nevertheless a 15 cm increased
spleen was found, containing in its cephalic portion a
hypoechoic and asymptomatic 70× 77mm solidmass. Color
Doppler showed blood flow along the edge of the round
mass, without relevant signals within the neoformation.
CT scan was also executed, to better evaluate the splenic
lesion: images before contrast material administration dis-
played a round mass, hypodense compared to the normal
splenic parenchyma. After injection of intravenous contrast,
it showed a mild contrast enhancement during the arterial
phase, followed by a complete washout during the late
venous phase, without relevant vascular components inside
(Figure 1).
After these preoperative findings suggestive but not
definitive for a well-defined histological lesion, considering
the high risk for splenic bleeding in the case of biopsy and
the risk for spontaneous rupture, the patient was candidate
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Figure 1: Computed tomography showing a hypodense mass of the
spleen with contrast enhancement during arterial phase.
for totally laparoscopic splenectomy two months after first
clinical evaluation. Routine preoperative examination, chest
X-ray, blood test, and anaesthesiologic evaluation did not set
any contraindication to the operation.
The patient was placed in a 30-degree right lateral
decubitus, with the help of a cushion positioned along his
back.
Right arm was arranged for intraoperative intravenous
fluid infusion, whereas left arm was suspended with
bendages above patient’s head to allow full access to the
left hemiabdomen. A 12mm disposable Hasson’s trocar
was placed using an open technique in supraumbilical
region for the first induction of pneumoperitoneum and
for optical access. A second 10–12mm disposable trocar
was positioned in left hypochondrium, at the intersection
between midclavicular line and infracostal line and two
more 5mm accesses, the first in left flank, along anterior
axillary line and the second in right hypochondrium, along
midclavicular line (Figure 2). Laparoscopic exploration of
the abdominal cavity was negative for any associated or
generalized pathology, as well as for accessory spleen. An
enlarged 15 cm spleen was identified; omental adhesions and
splenocolic ligament were dissected using monopolar and
ultrasonic dissector in order to lower the splenic flexure
of the colon and to expose the inferior pole of the organ.
Dissection was carried on with the section of the inferior
and superior gastrosplenic vessels. Thus the lesser peritoneal
sac was open, exposing the anterior side of the splenic hilum
and the pancreas tail; the stomach was retracted toward the
patient’s rightside. Vascular splenic pedicle was then isolated
at the hilum allowing identification of periferic branches of
splenic artery and vein.
Vessels were finally dissected using two vascular 30mm
endostapler refills (EndoGIA, Autosuture, Covidien, Mans-
field, MA, USA) obtaining a perfect hemostasis. Spleen
was then mobilized toward the patient’s right side, to
allow dissection of the posterior peritoneal reflection or
splenorenal ligament. After placing the totally freed organ
inside an EndoBag (EndoCatch II, Autosuture, Covidien,
Mansfield, MA, USA) a Pfannestiel suprapubic incision
was performed to remove the specimen. The peritoneal-sac
access was carried on with a partial surgical section of the
rectus muscle in order to allow an easier removal of the
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Figure 2: Disposition of trocars for laparoscopic splenectomy.
Figure 3: The removed specimen: spleen with a round capsulated
nodule of increased stiﬀness.
unbroken specimen. After clearing the spleen, laparotomic
incision was sealed inmultiple layers. An accurate hemostasis
control and a generous abdominal cavity washing were
performed after the recreation of pneumoperitoneum; a
single drainage was positioned in the left subphrenic space
and major accesses were finally closed.
A short-term perioperative antibiotic prophylaxis based
on cefazolin (1 gr every 8 hours) was administered for the
first 24 hours. Pain control was always optimal during the
entire hospitalization: during the first 24 hours after surgery
pain control was managed with opiates and paracetamol;
on the following day opiates were replaced with anti-
inflammatory nonsteroidal drugs removed from the 3rd day
on; during the same day the drainage was removed. The
patient was allowed to eat from the 2nd postoperative day.
The complete functionality of the gastrointestinal tract was
regained between the 3rd and 4th postoperative day. The
patient was dismissed on the 5th day after surgery and
stitches were removed 6 days later during an outpatient clini-
cal control. Vaccination against Streptococcus pneumoniae,
Haemophilus influenza type B, and Neisseria meningitidis
infections was administered 20 days after surgery. Perioper-
ative anticoagulant prophylaxis with subcutaneous heparin
(4000 I.U. per day) was applied and continued for 4 weeks
after surgery.
The anatomopathological analysis of the spleen showed
a 14 × 7 × 8 cm organ, weighting 430 gr, containing a
7,5 cm reddish brown nodule of slightly augmented stiﬀness,
compared to the surrounding splenic tissue (Figure 3). The
histopathological diagnosis confirmed the original suspect
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of splenic hamartoma, also supported by the immunohisto-
chemical stains positive for CD-8 and negative for CD-34.
3. Discussion
3.1. Diﬀerential Diagnosis. Solid lesions of the spleen are
quite rare and generally asymptomatic. About half of these
are accidentally detected during imaging studies carried out
for unrelated causes [18]. Diﬀerential diagnosis includes pri-
mary malignancies, in particular non-Hodgkin’s lymphoma
and angiosarcoma, which is the most common nonlymphoid
malignant primary tumor of the spleen [20]. Lung cancer,
melanoma, ovary, uterine cervix, and other nongastroin-
testinal tumors splenic metastasis are also reported [21, 22].
Benign lesions are extremely rare (7/100000 autopsies) and
have generally vascular origin [8]. Hemangioma, littoral
cell angioma, lymphangioma, hemangioendothelioma, and
hamartoma of the spleen have been previously described
in the literature [2–8]. Inflammatory miofibroblastic tumor,
disseminated fungal or mycobacterial infections, and sar-
coidosis are also included in the diﬀerential diagnosis [23].
Splenic hamartoma is a rare benign tumor which occurs
in any age group and has the same male and female occur-
rence. Its size tends to be longer in females, probably due to
hormonal influence on tumor growth [24–26]. The tumor is
usually detected as a singular lesion with a diameter ranging
from a few millimeters to several centimeters. Symptoms
such as pain, palpablemass, or spontaneous rupture are asso-
ciated with longer lesions. Hypersplenism, including throm-
bocytopenia, anemia, pancytopenia, or malignant hemato-
logic conditions, is described even if uncommon [27–29].
3.2. Imaging. It is diﬃcult to make a definitive preoper-
ative diagnosis basing on conventional imaging including
ultrasound and CT scan. Generally splenic hamartomas
present as homogeneous, hypoechoic masses with multiple
radial blood-flow signals at Color Doppler sonograms [30].
Contrast-enhanced sonography with microbubble contrast
agents shows that tumor could be markedly enhanced [31].
CT scan displays a hypoechoic lesion with a diﬀuse hetero-
geneous enhancement after intravenous administration of
contrast material [32].
3.3. Fine Needle Aspiration Biopsy. Fine needle aspiration
biopsy may be useful to establish a pathological diagnosis.
However this technique is associated with some dreadful
complications including bleeding and abdominal seeding.
These are the reasons why this procedure has been rarely
reported [24, 33, 34].
3.4. Histology. Histologically hamartoma presents as an over-
growth of the normal spleen components [33]. Microscopi-
cally there are two types of splenic hamartoma: follicular and
pulposal types. Splenic hamartoma is either of the pulposal
type resembling a splenic red pulp or a lymphoid type
resembling a white pulp. Symptomatic cases are invariably
of the red pulposal variety because of an increased number
of vascular channels which can sequester blood cells and
produce hypersplenism [13]. Clinical diagnosis may be
confirmed by immunopathological examination. Immuno-
histochemically endothelial cells of hamartoma are CD8-
positive and CD34-negative in contrast to the CD8 negative
and CD34 positive endothelial cells of hemangioma [34].
3.5. Surgery. Laparoscopic splenectomy (LS) is the standard
procedure for most of benign and malignant hematologic
diseases [15]. The laparoscopic approach reduces postop-
erative complications, in particular pulmonary ones such
as pneumonia and atelectasis as well as intra-abdominal
and wound infections and shortens recovery [35]. Never-
theless massive splenomegaly, defined as maximum diam-
eter exceeding 20 cm, represents a contraindication for
laparoscopy because in this case surgery may be more dif-
ficult, thus requiring significant experience [35]. Complica-
tions following LS generally relate with the size of the spleen
regardless of the underlying disease. A patient selection based
on splenic size on preoperative imaging is thus necessary.
Moreover LS has become the procedure of choice not only
for the management of hematologic diseases [36] but also for
the management of solid splenic tumors [11]. In these cases
splenectomy is performed in terms of diagnostic and staging
procedure considering the impossibility to make a definitive
preoperative diagnosis. Thus removal of the intact organ for
pathologic examination becomes necessary, being a further
diﬃculty in laparoscopic approach [37, 38]. On this issue
partial splenectomy is reported in the literature as a possible
alternative surgical procedure for benign cysts and in the
setting of unclear splenomegaly or inconclusive blood and
bone-marrow findings. It is mainly performed in children to
preserve the splenic immunologic function and its important
role in immune defense [39, 40]. Even splenic benign tumors,
including vascular neoplasms, may be suitable for partial
splenectomy. Nevertheless the impossibility in most of these
cases to assure a definitive preoperative diagnosis in addition
to technical limits, a higher risk of complications (rupture,
haemorrhage) and recurrences does not allow this surgery
to be routinely and entensively used. There are no large
series on LS for solid splenic lesions [18]. This is probably
justified by the rarity of this entity and by a diﬀuse reluctance
in treating them laparoscopically, specifically when they are
associated with splenomegaly. In particular only a few cases
of laparoscopic procedure for splenic hamartoma have been
reported in detail. In all these cases a hand-assisted laparo-
scopic splenectomy (HALS) was performed [16, 17, 19]. The
use of HALS technique oﬀers the undeniable advantage of
the palpation and detection of malignant lesions involving
adjacent structures (regional lymph nodes, pancreas, and
stomach). It also facilitates the identification of correct
planes and mobilization of the spleen by using the hand as
a retractor. In the case of bleeding it can be easily controlled
by manual compression of the splenic vascular pedicle
[37, 41–43]. Despite these undeniable benefits, the constant
improvement of technique in mini-invasive surgery and
the remarkable innovation of instruments have allowed the
diﬀusion of total laparoscopic approach as a safe procedure
for splenectomy. Therebymost of the cases of splenic tumors,
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particularly those with the lack of malignancy at preoperative
clinical and radiological examination, are suitable for a
total laparoscopic resection and HALS may be consequently
reserved only to those tumors with associated splenomegaly.
As a result of these considerations, thanks to the experience
gained in LS for hematologic disorders (e.g., autoimmune
thrombocytopenia, autoimmune hemolytic anemia), in the
present case we performed a total LS for splenic hamartoma.
A satisfactory result was achieved in terms of operative
time, blood loss, pain control, early hospital discharge, and
cosmetic results.
4. Conclusion
In conclusion the rapid advancement of imaging modalities
leads to the identification of more asymptomatic lesions of
the spleen. In most of these cases malignancy cannot be
ruled out by preoperative clinical and radiological evaluation
and surgery becomes necessary. In the absence of massive
splenomegaly total laparoscopic splenectomy may be a safe
and feasible procedure for the diagnosis and treatment of
both benign and malignant solid tumors of the spleen as
demonstrated by this particular case of splenic hamartoma.
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